Preventing Metastasis of High-Risk Melanoma
In the U.S., more than 7,000 people die from melanoma annually. Up to one-third of these deaths are caused by early, localized melanomas (AJCC Stage 1–2) that metastasize despite appropriate surgical treatment. There are no medical treatments designed to prevent early melanoma from progressing to metastatic disease. We are leveraging genetic expression data to discover medications that can halt this metastatic process.
‚— Wesley Yu, M.D.
- Oregon Health & Science University
- Career Development Award in Dermatologic Surgery
Categories: Featured Researchers
Tags: 2021 Research Awards, Chemoprevention, Melanoma, Nevi and Melanoma
Related Articles
Exploring Gene Expression Patterns and Biomarkers of Disease Severity in Central Centrifugal Cicatricial Alopecia
Central centrifugal cicatricial alopecia (CCCA), which has been associated with uterine fibroids, is unlike other scarring alopecias because fibrosis rather…
Characterizing the Microbiome in Postmenopausal Women with Vulvar Lichen Sclerosus
Vulvar lichen sclerosus is a chronic inflammatory condition that leads to scarring, obliteration of normal vulvar architecture, dyspareunia, and significant…
Cell Signaling Changes Induced by Surgical Debulking May Improve Response to Smoothened Inhibitor Therapy
Smoothened (SMO) inhibitors, such as vismodegib, are effective treatments for locally advanced basal cell carcinomas (BCCs). However, recurrences are frequent…